Heart Health

This news channel includes content on cardiovascular disease prevention, cardiac risk stratification, diagnosis, screening programs, and management of major risk factors that include diabetes, hypertension, diet, life style, cholesterol, obesity, ethnicity and socio-economic disparities.
 

A pediatric patient who was wounded by Russian fire during fighting in Kyiv, Ukraine, being triaged at the National Children's Specialized Hospital. #Ukraine #UkraineRussianWarb #civiliancasualties

War in Ukraine: Perfusionist from Ukraine asks clinicians to help his homeland

Ukrainian native and pediatric perfusionist Kyrylo Chasovskyi is now heading efforts to mobilize funds and supplies to send to his former pediatric hospital in Kyiv.

Thumbnail

Drinking wine with meals may lower risk of type 2 diabetes

The same benefit was not seen, however, when alcohol was consumed without food.

Thumbnail

Verapamil shows potential as a long-term oral treatment for type 1 diabetes

Much more research is still required — but could verapamil be the first oral medication for type 1 diabetes? 

Thumbnail

Long-term use of angiotensin-receptor blockers increases risk of cancer, new study confirms

These findings have “profound implications for patients and prescribing clinicians," one researcher said. 

Top cardiology stories in Cardiology Business magazine in February 2022. The top stories this month included new information on COVID vaccine caused myocarditis and the FDA clearance of the first transcatheter dual-chamber leadless pacemaker system from Abbott.

The top 20 Cardiology Business stories for February 2022

The most popular stories on Cardiology Business in February 2022 focused on COVID-19 updates, new technologies, an Olympics controversy and much more. 

Hypertension patients benefit from new intervention focused on education, motivation and text messages

Improving the way we communicate with ED patients about their blood pressure could make a significant long-term impact on their health. 

How modified bioprosthetic heart valves could limit calcification, reduce need for TAVR

Bioprosthetic heart valves often express foreign sugars that trigger a response from the body's immune system. This immune response appears to be associated with calcification. 

FDA approves empagliflozin for reducing risk of cardiovascular death, hospitalization among adult HFpEF patients

The SGLT2 inhibitor, already approved for some high-risk heart failure patients, has now received a much wider approval.